Fulcrum Therapeutics
FULC
FULC
61 hedge funds and large institutions have $374M invested in Fulcrum Therapeutics in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.52% more ownership
Funds ownership: 72.05% → 74.58% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
61
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$16.1M | |
| 2 | +$12.9M | |
| 3 | +$5.65M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$5.38M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$5.38M |
Top Sellers
| 1 | -$2.53M | |
| 2 | -$2.24M | |
| 3 | -$804K | |
| 4 |
CTB
Country Trust Bank
Bloomington,
Illinois
|
-$366K |
| 5 |
JP Morgan Chase
New York
|
-$301K |